Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8.80x is 34% above its 5-year average of -13.31x, near the high end of its 5-year range (-69.57x–-6.76x).
4.67% below its 12-month average of -8.41x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -8.25x.
INTEREST COVERAGE RATIO
-8.80x
INTEREST COVERAGE RATIO AVG TTM
-8.41x
INTEREST COVERAGE RATIO AVG 3Y
-13.04x
INTEREST COVERAGE RATIO AVG 5Y
-13.31x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.67%
CURRENT VS 3Y AVG
+32.52%
CURRENT VS 5Y AVG
+33.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
-56.17%
vs the sector median at left
CVRx, Inc.
Market Cap
$44.18M
Interest Coverage Ratio
-8.80x
TTM Avg
-8.41x
3Y Avg
-13.04x
5Y Avg
-13.31x
Market Cap
$43.99M
Interest Coverage Ratio
N/A
TTM Avg
53.13x
3Y Avg
53.13x
5Y Avg
53.13x
Market Cap
$44.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$45.21M
Interest Coverage Ratio
-11.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$45.37M
Interest Coverage Ratio
-10.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.92M
Interest Coverage Ratio
-16.47x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.70M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.06M
Interest Coverage Ratio
1146.00x
TTM Avg
576.00x
3Y Avg
576.00x
5Y Avg
576.00x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $44.18M | -8.80x | -8.41x | -13.04x | -13.31x |
| BioStem Technologies, Inc. (BSEM)vs › | $43.99M | N/A | 53.13x | 53.13x | 53.13x |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.30M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.21M | -11.50x | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $45.37M | -10.91x | N/A | N/A | N/A |
| Precipio, Inc. (PRPO)vs › | $41.92M | -16.47x | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.70M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $40.06M | 1146.00x | 576.00x | 576.00x | 576.00x |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.05M | -23.69x | N/A | N/A | N/A |
Interest Coverage
-8.8x
Debt/Equity
2.98
Current Ratio
8.04
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -8.25x |
| 2026-03-31 | -7.84x |
| 2025-12-31 | -7.89x |
| 2025-09-30 | -8.29x |
| 2025-06-30 | -9.76x |
| 2025-03-31 | -9.22x |
| 2024-12-31 | -6.76x |
| 2024-09-30 | -13.58x |
| 2024-06-30 | -14.57x |
| 2024-03-31 | -23.16x |
| 2023-12-31 | -16.69x |
| 2023-09-30 | -19.09x |
| 2023-06-30 | -24.43x |
| 2023-03-31 | -50.67x |
| 2022-12-31 | -69.57x |
| 2021-12-31 | -22.19x |
| 2021-09-30 | -11.87x |
| 2021-06-30 | -9.33x |
| 2021-03-31 | -7.02x |
| 2020-12-31 | -3.48x |
| 2020-09-30 | -4.90x |
| 2020-06-30 | -4.95x |
| 2020-03-31 | -5.31x |
